Outlook Therapeutics (OTLK) Stock Chart & Stock Price History → Major Elon Musk Crypto Leak Revealed (From Crypto 101 Media) (Ad) Free OTLK Stock Alerts $9.37 +0.69 (+7.95%) (As of 03/27/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Outlook Therapeutics Stock Price Performance5 Day Performance+8.57%1 Month Performance+7.09%3 Month Performance+9.80%6 Month Performance+114.71%Year-To-Date Performance+18.91%1 Year Performance-53.15% Receive OTLK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsThe AI Defense Stock Set to SoarTo protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.Here's how you can invest >>> OTLK Stock Chart for Thursday, March, 28, 2024 OTLK Chart by TradingView Outlook Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$8.68$9.37+7.95%$10.55$8.771.47 million shs$121.90 million03/26/2024$8.51$8.68+2.00%$8.97$8.13412,805 shs$112.95 million03/25/2024$8.63$8.51-1.39%$8.93$7.70826,227 shs$110.72 million03/22/2024$7.04$8.63+22.59%$11.72$8.3020.98 million shs$112.28 million03/21/2024$6.78$7.04+3.83%$7.74$6.80277,067 shs$91.59 million03/20/2024$7.41$6.78-8.44%$7.46$6.74278,107 shs$88.21 million Get the Latest News and Ratings for OTLK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024$7.79$7.41-4.88%$7.72$7.11202,755 shs$96.34 million03/18/2024$8.24$7.79-5.52%$8.42$7.31414,209 shs$101.28 million03/15/2024$5.73$8.24+43.80%$10.72$5.622.27 million shs$2.14 billion03/14/2024$6.46$5.73-11.33%$6.73$5.04569,045 shs$1.49 billion03/13/2024$6.99$6.46-7.58%$6.94$6.18175,992 shs$84.09 million03/12/2024$7.82$6.99-10.57%$7.69$6.40219,718 shs$90.99 million03/11/2024$7.90$7.82-1.09%$8.00$7.6749,322 shs$101.74 million03/08/2024$8.23$7.90-3.91%$8.22$7.6561,850 shs$102.86 million03/07/2024$8.10$8.23+1.56%$8.40$7.8058,772 shs$107.04 million03/06/2024$7.92$8.10+2.32%$8.40$7.9241,455 shs$105.41 million03/05/2024$8.45$7.92-6.34%$8.54$7.8085,001 shs$103.01 million03/04/2024$8.13$8.45+4.01%$8.60$8.2049,814 shs$109.99 million03/01/2024$8.74$8.13-6.98%$8.80$8.0082,616 shs$105.74 million02/29/2024$8.75$8.74-0.16%$9.00$8.7042,621 shs$113.68 million02/28/2024$8.86$8.75-1.22%$9.00$8.7031,646 shs$113.86 million02/27/2024$8.96$8.86-1.14%$9.10$8.6040,848 shs$115.27 million02/26/2024$8.77$8.96+2.14%$9.10$8.8428,713 shs$116.60 million02/23/2024$8.58$8.77+2.21%$9.20$8.6098,681 shs$114.15 million02/22/2024$8.36$8.58+2.66%$9.48$8.1968,332 shs$111.68 million02/21/2024$8.68$8.36-3.66%$8.92$8.2852,672 shs$108.79 million02/20/2024$9.03$8.68-3.92%$9.78$8.60106,717 shs$112.93 million02/19/2024$9.03$9.03$9.70$8.8294,045 shs$117.53 million02/16/2024$9.70$9.03-6.85%$9.69$8.8393,986 shs$117.53 million02/15/2024$8.41$9.70+15.35%$10.00$8.60257,552 shs$126.17 million02/14/2024$8.00$8.41+5.07%$8.80$7.6263,044 shs$109.39 million02/13/2024$8.75$8.00-8.53%$8.80$8.0046,023 shs$104.10 million02/12/2024$8.28$8.75+5.60%$9.00$8.4269,060 shs$113.81 million02/09/2024$8.97$8.28-7.69%$9.11$8.0754,100 shs$107.77 million02/08/2024$8.42$8.97+6.61%$9.20$8.42144,974 shs$116.75 million02/07/2024$7.69$8.42+9.44%$8.60$7.40122,891 shs$109.52 million02/06/2024$7.13$7.69+7.88%$7.70$7.1043,966 shs$100.07 million02/05/2024$7.28$7.13-2.14%$7.78$7.0641,612 shs$92.76 million02/02/2024$7.25$7.28+0.47%$7.40$7.0342,234 shs$94.79 million02/01/2024$7.72$7.25-6.09%$8.00$7.1587,516 shs$94.34 millionSHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.01/31/2024$8.30$7.72-6.99%$8.56$7.7290,041 shs$100.46 million01/30/2024$8.93$8.30-7.03%$9.00$8.3053,882 shs$108.01 million01/29/2024$8.64$8.93+3.33%$9.00$8.1969,292 shs$116.18 million01/26/2024$8.70$8.64-0.67%$9.00$8.2574,603 shs$112.43 million01/25/2024$8.00$8.70+8.73%$9.04$8.00216,024 shs$113.19 million01/24/2024$8.88$8.00-9.87%$9.20$7.83182,033 shs$104.10 million01/23/2024$6.80$8.88+30.53%$9.12$7.641.39 million shs$115.50 million01/22/2024$6.98$6.80-2.58%$7.00$5.8270,040 shs$88.49 million01/19/2024$7.15$6.98-2.32%$7.27$6.8639,663 shs$90.83 million01/18/2024$7.47$7.15-4.29%$7.40$7.1025,817 shs$92.99 million01/17/2024$7.69$7.47-2.86%$7.69$7.2225,636 shs$97.16 million01/16/2024$7.36$7.69+4.37%$7.80$7.2548,102 shs$100.02 million01/15/2024$7.36$7.36$7.80$7.3018,920 shs$95.83 million01/12/2024$7.58$7.36-2.90%$7.80$7.3018,808 shs$95.83 million01/11/2024$7.60$7.58-0.21%$7.73$7.4624,283 shs$98.69 million01/10/2024$7.44$7.60+2.10%$7.76$7.4421,556 shs$98.90 million01/09/2024$7.60$7.44-2.05%$7.83$7.2351,729 shs$96.87 million01/08/2024$7.66$7.60-0.76%$7.98$7.4144,223 shs$98.90 million01/05/2024$7.80$7.66-1.82%$7.96$7.5032,012 shs$99.65 million01/04/2024$8.34$7.80-6.47%$8.41$7.6063,377 shs$101.50 million01/03/2024$7.86$8.34+6.08%$8.49$7.79138,787 shs$108.53 million01/02/2024$7.88$7.86-0.23%$8.53$7.8341,267 shs$102.31 million01/01/2024$7.88$7.88$9.27$7.82125,060 shs$102.54 million12/29/2023$8.53$7.88-7.66%$9.22$7.82124,978 shs$102.54 million12/28/2023$9.25$8.53-7.76%$9.38$8.41237,647 shs$111.05 million12/27/2023$8.92$9.25+3.72%$10.00$9.00298,290 shs$120.39 million Related Companies: Protalix BioTherapeutics Stock Chart Cardiol Therapeutics Stock Chart Vigil Neuroscience Stock Chart Athira Pharma Stock Chart AlloVir Stock Chart CEL-SCI Stock Chart Elutia Stock Chart Instil Bio Stock Chart Passage Bio Stock Chart BioAtla Stock Chart Receive OTLK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OTLK) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outlook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.